EUCTR2006-004257-14-DK进行中（未招募）1 期
A Multicenter, Double-Blind, Placebo and Active-Controlled, Parallel Group Study to Compare the Efficacy and Safety of Oral MK-0974 With Placebo and Zolmitriptan for the Acute Treatment of Migraine With or Without Aura - MK-0974 Pivotal Study 1 - worldwide (with active comparator)
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 1,800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Patient has at least 1 year history of migraine (with or without aura).
- •Females of child bearing potential must use acceptable contraception throughout trial.
- •Patient is in general good health based on screening assessment.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patient is pregnant/breast-feeding (or is a female expecting to conceive during study period).
- •Patient has uncontrolled hypertension (high blood pressure), uncontrolled diabetes, HIV disease, or other significant disease.
- •Patient has major depression, other pain syndromes that might interfere with study assessments, psychiatric conditions, dementia, or significant neurological disorders (other than migraine).
- •Patient has a history of gastric, or small intestinal surgery, or has a disease that causes malabsorption.
- •Patient has a history of cancer within the last 5 years.
- •Patient has history or presence of a significant cardiovascular disorder (e.g. acute
- •coronary syndrome [e.g. MI or unstable angina]; coronary artery intervention [e.g.
- •CABG or PTCA]; congestive heart failure or arrhythmia.
- •Note: Patients with evidence of an MI on ECG will be excluded.
研究者
相似试验
进行中（未招募）
1 期
A global study completed at hospitals in US, Europe & Asia using an investigational drug (Perampanel) to research its safety & effectiveness in patients who are at least 2 years of age with Lennox-Gastaut SyndromeSeizures associated with Lennox-Gastaut Syndrome (LGS)MedDRA version: 20.0Level: PTClassification code 10048816Term: Lennox-Gastaut syndromeSystem Organ Class: 10029205 - Nervous system disordersEUCTR2014-002321-35-PLEisai Limited70
进行中（未招募）
不适用
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects With Acute Coronary Syndrome: Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA•CER) - TRA•CERMedDRA version: 9.1Level: LLTClassification code 10051592Term: Acute coronary syndromeAcute Coronary SyndromeEUCTR2006-002809-31-ATSchering Plough Research Institute, a Division of Schering Corporation12,500
进行中（未招募）
1 期
A Clinical study to assess the safety and effectiveness of ARN-509 in men with Castration-Resistant Prostate Cancer (prostate cancer not responsive to castration treatment)Castration-Resistant Prostate CancerMedDRA version: 21.1Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-004322-24-DKAragon Pharmaceuticals, Inc1,200
进行中（未招募）
1 期
A Multi-centre, Randomised, Double-Blind, Placebo-Controlled Study to evaulate the Safety and Efficacy of Pulmaquin® (ARD-3150, Dual Release Coprofloxacin for Inhalation) in subjects who have a lung infection that includes the bacteria Pseudomonas aeruginosa due to the non-cystic fibrosis bronchiectasisChronic lung infections with Pseudomonas aeruginosa in subjects with non-cystic fibrosis bronchiectasisMedDRA version: 16.1Level: LLTClassification code 10057582Term: Lung infection pseudomonalSystem Organ Class: 100000004862MedDRA version: 16.1Level: LLTClassification code 10006446Term: Bronchiectasis NOSSystem Organ Class: 100000004855EUCTR2013-005366-19-GBAradigm Corporation255
进行中（未招募）
1 期
A Trial to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of AgeChronic MigraineMedDRA version: 20.0Level: HLTClassification code 10027603Term: Migraine headachesSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 21.1Level: LLTClassification code 10066636Term: Chronic migraineSystem Organ Class: 10029205 - Nervous system disordersEUCTR2019-002053-33-DETeva Branded Pharmaceutical Products R&D, Inc.278